Table 1.

Clinical and immunological characteristics of SSc patients.

	SScpatients n = 35
SSctype
lcSSc (n,%)	23 (65.7)
dcSSc (n,%)	12 (34.3)
Rodnan skin score (mean ± SD)	7.24 ± 8.3
Pulmonary fibrosis (n,%)	12 (34.3)
Pulmonary arterial hypertension (n,%)	2 (5.7)
Ulcers (n,%)	12 (34.7)
GI INVOLVEMENT
Upper (n,%)	20 (57.1)
Lower (n,%)	0
Both (n,%)	1 (2.9)
Arthritis (n,%)	13 (37.1)
Serositis (n,%)	4 (11.4)
Telangiectasia (n,%)	18 (51.4)
Calcinosis (n,%)	2 (5.7)
Renal crisis (n,%)	0
Overlap syndrome/MCTD (n,%)	8 (25.0)
Dry mouth (n,%)	13 (37.5)
Dry eyes (n,%)	8 (22.9)
Rash (n,%)	7 (20.0)
Acro-osteolysis (n,%)	5 (14.3)
AUTOANTIBODIES
-Scl-70 (n,%)	5 (14.3)
-CENPA (n,%)	14 (40.0)
-CENPB (n,%)	14 (40.0)
-RP11 (n,%)	1 (3.1)
-RP155 (n,%)	3 (9.4)
-Fibrillarin (n,%)	1 (3.1)
-NOR90 (n,%)	3 (9.4)
-Th/To (n,%)	0 (0)
-PM-Scl 100 (n,%)	0 (0)
-PM-Scl 75 (n,%)	2 (6.3)
-Ku (n,%)	4 (12.5)
-PDGFR (n,%)	0 (0)
-Ro52 (n,%)	35 (100)
-Ro60 (n,%)	13 (37.1)
-La (n,%)	5 (14.3)